ah 6809 has been researched along with h 89 in 7 studies
| Studies (ah 6809) | Trials (ah 6809) | Recent Studies (post-2010) (ah 6809) | Studies (h 89) | Trials (h 89) | Recent Studies (post-2010) (h 89) |
|---|---|---|---|---|---|
| 163 | 1 | 49 | 1,619 | 0 | 409 |
| Protein | Taxonomy | ah 6809 (IC50) | h 89 (IC50) |
|---|---|---|---|
| Rho-associated protein kinase 2 | Homo sapiens (human) | 1.9504 | |
| Ribosomal protein S6 kinase alpha-5 | Homo sapiens (human) | 0.12 | |
| cAMP-dependent protein kinase catalytic subunit alpha | Bos taurus (cattle) | 0.073 | |
| cAMP-dependent protein kinase catalytic subunit alpha | Mus musculus (house mouse) | 0.381 | |
| cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | 0.6365 | |
| cAMP-dependent protein kinase catalytic subunit gamma | Homo sapiens (human) | 0.6365 | |
| cAMP-dependent protein kinase catalytic subunit beta | Homo sapiens (human) | 0.6365 | |
| Ribosomal protein S6 kinase beta-1 | Homo sapiens (human) | 0.08 | |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | 1.9886 | |
| RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | 0.5417 | |
| Rho-associated protein kinase 2 | Rattus norvegicus (Norway rat) | 0.27 | |
| RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | 0.3207 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kinsella, BT; Walsh, MT | 1 |
| Bonewald, LF; Cheng, B; Cherian, PP; Gu, S; Jiang, JX; Sprague, E | 1 |
| Belvisi, MG; Catley, MC; Clarke, DL; Giembycz, MA; Newton, R; Yacoub, MH | 1 |
| Abruzzese, JL; Cognetti, F; McConkey, DJ; Nawrocki, ST; Pino, MS; Xiong, HQ | 1 |
| Cho, EA; Juhnn, YS; Kim, SH; Kim, WH; Oh, JM; Song, YS | 1 |
| Liu, J; Qian, X; Zhang, J | 1 |
| Lee, YS; Shehzad, A; Yeo, HS | 1 |
7 other study(ies) available for ah 6809 and h 89
| Article | Year |
|---|---|
Regulation of the human prostanoid TPalpha and TPbeta receptor isoforms mediated through activation of the EP(1) and IP receptors.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Biological Transport; Blood Platelets; Calcium; Cells, Cultured; Dinoprostone; Drug Interactions; Enzyme Inhibitors; Epoprostenol; Humans; Indoles; Isoquinolines; Maleimides; Prostaglandin Antagonists; Prostaglandins; Protein Isoforms; Receptors, Epoprostenol; Receptors, Prostaglandin; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Thromboxane; Signal Transduction; Sulfonamides; Vasoconstrictor Agents; Xanthenes; Xanthones | 2000 |
Effects of mechanical strain on the function of Gap junctions in osteocytes are mediated through the prostaglandin EP2 receptor.
Topics: Adenylyl Cyclases; Animals; Blotting, Western; Cell Line; Cells, Cultured; Connexin 43; Culture Media, Conditioned; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclooxygenase 2; Dinoprostone; Gap Junctions; Isoenzymes; Isoquinolines; Models, Biological; Osteocytes; Prostaglandin Antagonists; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Stress, Mechanical; Sulfonamides; Time Factors; Xanthones | 2003 |
Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 8-Bromo Cyclic Adenosine Monophosphate; Adenoviridae; Adolescent; Adult; Aged; Alprostadil; Cell Survival; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; Enzyme Inhibitors; Female; Gene Expression; Genetic Vectors; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Indomethacin; Interleukin-1; Isoquinolines; Male; Middle Aged; Misoprostol; Myocytes, Smooth Muscle; Prostaglandins E, Synthetic; Protein Isoforms; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Signal Transduction; Sulfonamides; Trachea; Xanthones | 2004 |
Prostaglandin E2 drives cyclooxygenase-2 expression via cyclic AMP response element activation in human pancreatic cancer cells.
Topics: Cell Line, Tumor; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Cyclooxygenase 2; Dinoprostone; Enzyme Activation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Isoquinolines; Models, Biological; Pancreatic Neoplasms; Phosphorylation; Prostaglandin Antagonists; Sulfonamides; Xanthones | 2005 |
Human papillomavirus type 16 E5 protein inhibits hydrogen-peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells.
Topics: Androstadienes; Apoptosis; bcl-2-Associated X Protein; Biphenyl Compounds; Carcinoma, Squamous Cell; Cell Line, Transformed; Cell Line, Tumor; Cyclic AMP-Dependent Protein Kinases; Cycloheximide; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Female; Humans; Hydrogen Peroxide; Isoquinolines; Neoplasm Proteins; Oncogene Proteins, Viral; Proteasome Endopeptidase Complex; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype; RNA, Small Interfering; Sulfonamides; Ubiquitin; Uterine Cervical Neoplasms; Wortmannin; Xanthones | 2010 |
Tumor-secreted PGE2 inhibits CCL5 production in activated macrophages through cAMP/PKA signaling pathway.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bacterial Infections; Cell Line; Chemokine CCL5; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; Interferon-gamma; Interleukin-2; Isoquinolines; Lipopolysaccharides; Macrophage Activation; Macrophages; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Nitrobenzenes; Prostaglandin Antagonists; Protein Kinase Inhibitors; Shock, Septic; Signal Transduction; Sulfonamides; Tumor Escape; Xanthones | 2011 |
Prostaglandin E2 blocks menadione-induced apoptosis through the Ras/Raf/Erk signaling pathway in promonocytic leukemia cell lines.
Topics: Apoptosis; Cell Survival; Cell Transformation, Neoplastic; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Isoquinolines; Lamin Type B; Leukemia; Lipid Peroxidation; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Receptors, Prostaglandin E, EP2 Subtype; Sulfonamides; Vitamin K 3; Xanthones | 2012 |